BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Ivermectin

A mixture of mostly avermectin H2B1a (RN 71827-03-7) with some avermectin H2B1b (RN 70209-81-3), which are macrolides from STREPTOMYCES avermitilis. It binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. It also interacts with other CHLORIDE CHANNELS. It is a broad spectrum antiparasitic that is active against microfilariae of ONCHOCERCA VOLVULUS but not the adult form.

298+ PubMed studies analyzed · 5 RCTs · Evidence Score: 40.6

Research Domains

Ivermectin has been studied across 5 research domains including ✨ Skin & Hair, 🦠 Gut & Microbiome, 🫁 Liver & Detox, 🔬 Oncology, 😴 Sleep. The primary research focus is ✨ Skin & Hair with 5% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ivermectin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

terconazole
9 shared targets
oxybutynin
6 shared targets
sulconazole
10 shared targets
oxiconazole
9 shared targets
haloprogin
7 shared targets
doxepin
8 shared targets
difluorobenztropine
4 shared targets
clomipramine
9 shared targets
quinacrine
7 shared targets
clemastine
9 shared targets
Loading evidence profile...

This evidence profile for Ivermectin is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.